Ingevity Stock Up 23% in 3 Months: What's Driving the Rally?

Zacks01-02

Ingevity Corporation’s NGVT shares have shot up 23.3% over the past three months. The company has also outperformed the Zacks Chemicals Specialty industry’s decline of 9.8% over the same time frame. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2500974304?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-02 22:25","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2500974304","market":"us","top_or_hot":-1,"title":"Ingevity Stock Up 23% in 3 Months: What's Driving the Rally?","media":"Zacks","content":"<div>\n<p>Ingevity Corporation’s NGVT shares have shot up 23.3% over the past three months. The company has also outperformed the Zacks Chemicals Specialty industry’s decline of 9.8% over the same time frame. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ingevity-stock-23-3-months-142500087.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ingevity Stock Up 23% in 3 Months: What's Driving the Rally?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIngevity Stock Up 23% in 3 Months: What's Driving the Rally?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-02 22:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/ingevity-stock-23-3-months-142500087.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Ingevity Corporation’s NGVT shares have shot up 23.3% over the past three months. The company has also outperformed the Zacks Chemicals Specialty industry’s decline of 9.8% over the same time frame. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ingevity-stock-23-3-months-142500087.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4006","symbol_name":"钢铁","start_time":0,"source_url":"https://finance.yahoo.com/news/ingevity-stock-23-3-months-142500087.html","article_id":"2500974304","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2500974304","pubTimestamp":1735827900,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Ingevity Corporation’s NGVT shares have shot up 23.3% over the past three months. The company has also outperformed the Zacks Chemicals Specialty industry’s decline of 9.8% over the same time frame.Let’s take a look into the factors that are driving NGVT stock.NGVT currently has a Zacks Rank #3 .Better-ranked stocks in the Basic Materials space are Carpenter Technology Corporation CRS, ICL Group Ltd ICL and Gold Royalty Corp. GROY. While CRS sports a Zacks Rank #1 , ICL and GROY carry a Zacks Rank #2  each. You can see the complete list of today’s Zacks #1 Rank stocks here.Carpenter Technology beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 14.1%. CRS’ shares have soared 150% in the past year.The Zacks Consensus Estimate for ICL Group’s current-year earnings has increased by 2.9% in the past 60 days. ICL beat the consensus estimate in each of the last four quarters with the average surprise being 18.1%.Gold Royalty beat the ","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4006":"钢铁","IE0031619046.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) INC","ICL":"以色列化学","IE00B66KJ199.SGD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY  \" A\" (SGD) ACC","GROY":"Gold Royalty Corp","CRS":"卡朋特科技","IE00B7SZL793.SGD":"Legg Mason Royce - US Small Cap Opportunity A Acc SGD-H","BK4093":"化肥与农用药剂","NGVT":"Ingevity Corporation When Issued","IE00B19Z4B17.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) ACC","BK4109":"特种化学制品","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","BK4017":"黄金"},"translate_title":"Ingevity股价3个月内上涨23%：是什么推动了上涨？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRS":1,"ICL":1,"NGVT":1,"GROY":0.9},"content_text":"Ingevity Corporation’s NGVT shares have shot up 23.3% over the past three months. The company has also outperformed the Zacks Chemicals Specialty industry’s decline of 9.8% over the same time frame. Let’s take a look into the factors that are driving NGVT stock.\nImage Source: Zacks Investment Research\nNGVT Gains on Strategic Repositioning and Acquisitions\nIngevity is taking several actions to expand capacity and drive long-term growth. It remains committed to investing organically. Ingevity is also committed to capturing the maximum value for its products.The company is expected to benefit from the repositioning of its Performance Chemicals segment, which is aimed at lowering exposure to lower-margin end markets. The move includes consolidating segment operations at its North Charleston facility by moving oleo chemical refining to the North Charleston site’s secondary refinery as well as the closure of its Crossett facility. These actions further simplify the segment’s manufacturing footprint and create significant cost savings. NGVT expects this manufacturing consolidation to result in around $20-$25 million in annual savings beginning in 2025.During the third quarter, the company began to notice the benefits of the repositioning. Ingevity’s focus over the next few quarters will be on execution to ensure that it maximizes the benefits of its approach. Operational improvements leading to lower input costs and better manufacturing efficiency are also aiding performance in its Performance Materials unit. The acquisition of the Capa caprolactone business enabled the company with a new technology platform to drive revenue and earnings growth. Capa has a strong and market-leading business that focuses on high-growth end-use applications. NGVT, in July 2024, expanded its Capa caprolactone distribution network by selecting Ultrapolymers Group as the distributor for Capa Bioplastics in Europe. The acquisition of Ozark Materials has also strengthened the company’s position in the paving construction industry.\n\nIngevity Corporation Price and Consensus\n\nIngevity Corporation price-consensus-chart | Ingevity Corporation Quote\n\nNGVT’s Zacks Rank & Key Picks\nNGVT currently has a Zacks Rank #3 (Hold).Better-ranked stocks in the Basic Materials space are Carpenter Technology Corporation CRS, ICL Group Ltd ICL and Gold Royalty Corp. GROY. While CRS sports a Zacks Rank #1 (Strong Buy), ICL and GROY carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.Carpenter Technology beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 14.1%. CRS’ shares have soared 150% in the past year. The Zacks Consensus Estimate for ICL Group’s current-year earnings has increased by 2.9% in the past 60 days. ICL beat the consensus estimate in each of the last four quarters with the average surprise being 18.1%. Gold Royalty beat the consensus estimate in three of the trailing four quarters while delivering in-line results on the other occasion. In this time frame, it has delivered an earnings surprise of roughly 125%, on average. GROY has an expected earnings growth rate of 66.7% for the current year.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nCarpenter Technology Corporation (CRS) : Free Stock Analysis Report\nICL Group Ltd. (ICL) : Free Stock Analysis Report\nIngevity Corporation (NGVT) : Free Stock Analysis Report\nGold Royalty Corp. (GROY) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2500974304"}